This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Eleuthero (Siberian Ginseng)
The original "Russian adaptogen" — popularized in 1960s Soviet sport-medicine and military-performance research under Israel Brekhman's lineage at the Far East Branch of the USSR Academy of Sciences.
Aliases (11)
Overview
What is Eleuthero (Siberian Ginseng)?
Eleuthero (Eleutherococcus senticosus, Siberian ginseng) is an adaptogenic herb traditionally used in Russian and East Asian medicine. It is not true ginseng (Panax) but a related Araliaceae species.
Key Benefits
Supports stress resilience, mild cognitive enhancement under fatigue, and immune modulation. Anecdotally improves endurance and recovery from over-training. Lower stimulant burden than Panax ginseng.
Mechanism of Action
Eleutherosides modulate the HPA axis, reducing cortisol response to stressors. Additional effects on monoamine signaling, NF-kB inhibition, and NK cell activity. Classic 'adaptogen' profile per Brekhman.
Pharmacokinetics
Research Indications
HPA-axis modulation
Eleutherosides modulate cortisol response to acute stressors in animal restraint-stress and swim-stress models. The proposed mechanism is…
Immune modulation
The most replicated mechanistic story. - Polysaccharide fraction activates macrophages (TNF-α + IL-1β + nitric oxide production in vitro)…
Cognitive endurance / fatigue
Soviet sport-medicine literature (1960s-70s, Brekhman lab and downstream) reports improved physical work capacity, reduced perceived exer…
Mild anti-inflammatory + antioxidant
Eleutherosides have modest free-radical-scavenging activity in vitro. Reduces inflammatory marker elevations in animal stress models. Lik…
Cardiovascular
Mild vasodilation reported. Russian sport-medicine data report improved cardiovascular endurance, but this is the same null-in-modern-RCT…
BDNF + neuroprotection
Animal models show eleutheroside-mediated increase in BDNF expression in hippocampus. Recent 2025 work (Frontiers Neuroscience, Korsakoff…
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
(in Dylan's V4): Both classical Russian adaptogens; rhodiola is more stimulating + monoamine-skewed, eleuthero more immune-skewed. However, stacking them sim…
Russian "ADAPT-232" three-adaptogen combo; both mild stimulants
Immune-modulation combo; common in Chinese herbal practice
Documented URTI synergy (Narimanian 2005, Materazzi 2015)
Immune-modulation combos; mechanistic overlap, no head-to-head data
(in V4 stack): General immune-support combo
Compound adaptogen; increases stim-like signal — not recommended for stimulant-sensitive users
(caffeine + modafinil + rhodiola + eleuthero simultaneously): Mild additive sympathomimetic; can cause anxiety + insomnia in stimulant-sensitive users
Theoretical interaction; case report of altered INR; mechanism unclear (possibly CYP1A2 or platelet effect); monitor if on warfarin
Case report of falsely elevated serum digoxin (assay interference rather than pharmacological); monitor levels if on cardiac glycoside
(phenelzine): Theoretical pressor risk; not well-characterized
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 7
Side Effects
- 1Mild GI upset (nausea, occasionally loose stool) — taking with food mitigates
- 2Drowsiness in some users (paradoxical given the "energy" framing — individual variability is high)
- 3Mild headache — usually transient
- 4Mild blood pressure elevation at high doses (≥800 mg/d) — sympathomimetic-like signal, less than Panax ginseng but real. Hypertensive users should monitor.
- 5Insomnia at PM dosing in stimulant-sensitive users
- 6Tachycardia at high doses (rare at standard doses)
- 7Mild hypoglycemia signal at higher doses (relevant for diabetic users on insulin/sulfonylureas)
When to Stop
- Allergic reactions to Araliaceae plants — rare; full anaphylaxis very rare
- Mastalgia (breast tenderness) — reported in older literature, mechanism unclear, may relate to product adulteration with hormonally-active species (see Patyra 2025 on Periploca sepium contamination causing one case of neonatal androgenization that was attributed to eleuthero but actually was the adulterant)
- First 2 weeks: GI tolerability + stimulating-effect check
- At high doses (>600 mg): Blood pressure check; insomnia screening
- After 6-8 weeks continuous: Watch for effect plateau / fade — time to cycle off
- Pregnancy / breastfeeding: Safety data inadequate; avoid by default
- Active hypertension uncontrolled: Caution / avoid at high doses
- Drug-tested athletes: Eleuthero is NOT WADA-banned. Documented Russian sports-medicine use. Still subject to product-purity verification (adulteration with banned substances is a sourcing risk, not a drug risk).
- 20 yo, no cardiac history, no hypertension, no diabetes, no drug-test concerns
- Stimulant-sensitive at baseline (zero caffeine, low substance baseline) — PM dosing risk is real; keep to AM
- MMA training + business workload = high cumulative stress; tolerability profile favorable
- Net risk: Very low at standard doses; no hard contraindications. Risk-reward calculus is dominated by the modest expected benefit, not by side-effect risk.
References
Patyra et al. 2025 — Eleutherococcus root comprehensive review of phytochemistry and pharmacological potential (Front Pharmacol, PMID 41235111)
Kos et al. 2025 — Eleutherococcus senticosus: An important adaptogenic plant (Molecules, PMID 40572479)
Tóth-Mészáros et al. 2023 — Adaptogenic plants on stress: systematic review and meta-analysis (J Funct Foods)
Materazzi et al. 2015 — Antitussive effect of Justicia + Echinacea + Eleutherococcus fixed combination in URTI (PMID 26598919)
Schaffler et al. 2013 — No benefit adding eleutherococcus senticosus to stress management training in asthenia (Pharmacopsychiatry, PMID 23740477)
Panossian & Wikman 2009 — Evidence-based efficacy of adaptogens in fatigue (Curr Clin Pharmacol, PMID 19500070)
Goulet & Dionne 2005 — Assessment of the effects of eleutherococcus senticosus on endurance performance (Int J Sport Nutr Exerc Metab, PMID 15902991)
Narimanian et al. 2005 — Randomized trial of KanJang fixed combination (Adhatoda + Echinacea + Eleutherococcus) in URTI (Phytomedicine, PMID 16121513)
Hartz et al. 2004 — Randomized controlled trial of Siberian ginseng for chronic fatigue (Psychol Med, PMID 14971626)
Cicero et al. 2004 — Effects of Siberian ginseng on elderly quality of life: RCT (Arch Gerontol Geriatr Suppl, PMID 15207399)
Glatthaar-Saalmüller et al. 2001 — Antiviral activity of eleutherococcus root extract (Antiviral Res, PMID 11397509)
Davydov & Krikorian 2000 — Eleutherococcus senticosus as an adaptogen: a closer look (J Ethnopharmacol, PMID 10996277)
Bohn et al. 1987 — Eleutherococcus on lymphocyte populations (Arzneimittelforschung, PMID 3675611)
EMA Assessment Report on Eleutherococcus senticosus root
EU regulatory monograph; approved for symptoms of asthenia
View StudyLatest research
- reviewEleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect (Patyra et al.)Frontiers in Pharmacology 2025 comprehensive review. Confirms eleutherosides B + E as standardization markers. Catalogs preclinical adaptogenic mechanism: anti-inflammatory + immunomodulatory (MAPK, Akt, NF-κB inhibition) plus neuroprotection (BDNF elevation). Critical finding: eleutheroside content varies 43-200x across commercial products; DNA barcoding identified adulterants in 30-36% of market samples. Clinical evidence remains low-quality and heterogeneous despite EMA approval for asthenia.
- reviewEleutherococcus senticosus (Acanthopanax senticosus): An Important Adaptogenic Plant (Kos et al.)Molecules 2025 review. Catalogs phytochemistry (eleutherosides, lignans, saponins, flavonoids, polysaccharides); neuroprotective signal in AD + PD animal models; antidiabetic + glucose regulation; immunostimulatory + antioxidant activity. Notes wild-harvest sustainability concerns (endangered in parts of native range) pushing biotech / cultivated supply.
- meta-analysisThe effect of adaptogenic plants on stress: A systematic review and meta-analysis (Tóth-Mészáros et al.)Journal of Functional Foods 2023 systematic review of 25 RCTs across 9 adaptogenic herbs (E. senticosus, Rhodiola, ashwagandha, etc.). Only Withania somnifera (ashwagandha) data were robust enough to meta-analyze for cortisol reduction (MD −3.27 µg/dL, p=0.003). Eleutherococcus trials too few + heterogeneous to pool; one trial reported no severe adverse events. Supports ashwagandha-over-eleuthero verdict for HPA-axis endpoints.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.